Status:

RECRUITING

Investigational Use of Neuromuscular Ultrasound

Lead Sponsor:

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Muscular Dystrophy

Peripheral Neuropathy

Eligibility:

All Genders

18-110 years

Brief Summary

Background: Current techniques used to measure the health and function of a person s nerves and muscles are generally effective, but they do have limits. Researchers are looking for ways to improve t...

Detailed Description

Study Description: Currently there are a limited number of biomarkers that can provide quantitative, reliable information about nerve and muscle function and structure in patients with neuromuscular ...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Healthy Volunteers-Adults
  • Healthy adults, male or female, aged 18 years old or older,
  • In good general health as evidenced by medical history, medical conditions under control such as hypertension acceptable.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Ability of subject to understand and the willingness to sign a written informed consent document.
  • Participants with neuromuscular disorders
  • Adults, male or female, aged 18 years old or older,
  • Diagnosed with a neuromuscular disorder or have signs and symptoms of nerve or muscle disorder or neuromuscular diaphragm dysfunction.
  • Stated willingness to comply with all study procedures and availability for the duration of the study.
  • Ability of subject to understand and the willingness to sign a written informed consent document.
  • EXCLUSION CRITERIA:
  • Healthy Volunteers-Adults
  • History of stroke, muscle disorders, peripheral neuropathy, or spine surgery
  • Participants with neuromuscular disorders
  • No clinical evidence of a neuromuscular disorder on clinical evaluation.

Exclusion

    Key Trial Info

    Start Date :

    April 18 2022

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 3 2026

    Estimated Enrollment :

    150 Patients enrolled

    Trial Details

    Trial ID

    NCT05237973

    Start Date

    April 18 2022

    End Date

    August 3 2026

    Last Update

    October 24 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892